{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:44:26Z","timestamp":1783154666797,"version":"3.54.6"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Antithrombotic medication is taken by 14\u201322% patients undergoing skin surgery, with more patients now taking direct oral anticoagulants (DOACs). The latest evidence suggests that the risk of stopping DOACs perioperatively is low in skin surgery, particularly for primary closures, but remains unclear for more complex procedures. The 2016 British Society for Dermatological Surgery (BSDS) guidelines suggest that clinicians could consider stopping DOACs in patients for 24\u201348\u2005h, based on individual bleeding risk. We surveyed BSDS members to better understand clinical practice and guideline adherence with a view to updating the guidance. The results demonstrated that there is consistency among clinicians in the management of patients on more established antithrombotic agents, such as aspirin, clopidogrel and warfarin. However, there is a higher perceived risk of significant haematomas following higher-risk procedures such as larger flaps or grafts with DOACs vs. other antithrombotics postoperatively. Stopping DOACs perioperatively for 24\u201348\u2005h for higher-risk procedures can be cautiously considered following an individual risk assessment and informed discussion with the patient.<\/jats:p>","DOI":"10.1093\/ced\/llad312","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T03:04:55Z","timestamp":1694487895000},"page":"143-145","source":"Crossref","is-referenced-by-count":3,"title":["A national clinician survey on the British Society for Dermatological Surgery guidelines on antithrombotic agent use in skin surgery"],"prefix":"10.1093","volume":"49","author":[{"given":"Eman","family":"Butt","sequence":"first","affiliation":[{"name":"University Hospitals Birmingham NHS Trust , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Hunt","sequence":"additional","affiliation":[{"name":"University Hospitals Plymouth NHS Trust , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Defty","sequence":"additional","affiliation":[{"name":"Walsall Healthcare NHS Trust , Walsall , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walayat","family":"Hussain","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospitals NHS Trust , Leeds , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bray","sequence":"additional","affiliation":[{"name":"Bristol Royal Infirmary , Bristol , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5920-6888","authenticated-orcid":false,"given":"Aaron","family":"Wernham","sequence":"additional","affiliation":[{"name":"Walsall Healthcare NHS Trust , Walsall , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"2024012519204013200_llad312-B1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/bjd.21062","article-title":"An international clinician \u00adsurvey CompAring Nonabsorbable Vs. Absorbable sutures for\u00a0Skin surgery: the CANVAS study","volume":"187","author":"Lee","year":"2022","journal-title":"Br J Dermatol"},{"key":"2024012519204013200_llad312-B2","author":"Bray"},{"key":"2024012519204013200_llad312-B3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/bjd.13362","article-title":"Perioperative management of and recommendations for antithrombotic medications in dermatological surgery","volume":"172","author":"Palamaras","year":"2015","journal-title":"Br J Dermatol"},{"key":"2024012519204013200_llad312-B4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jaad.2011.02.012","article-title":"Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications","volume":"65","author":"Bordeaux","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2024012519204013200_llad312-B5","author":"Bray"},{"key":"2024012519204013200_llad312-B6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaad.2020.10.008","article-title":"Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery","volume":"84","author":"Siscos","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2024012519204013200_llad312-B7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jaad.2017.05.038","article-title":"Perioperative complications with new oral anticoagulants dabigatran, apixaban, and rivaroxaban in Mohs micrographic surgery: a retrospective study","volume":"77","author":"Antia","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2024012519204013200_llad312-B8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/DSS.0000000000001394","article-title":"A retrospective assessment of postoperative bleeding complications in anticoagulated patients following Mohs micrographic surgery","volume":"44","author":"Eilers RE","year":"2018","journal-title":"Dermatol Surg"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llad312\/52174469\/llad312.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/2\/143\/56420917\/llad312.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/2\/143\/56420917\/llad312.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T19:20:49Z","timestamp":1706210449000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/49\/2\/143\/7269166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":8,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,9,11]]},"published-print":{"date-parts":[[2024,1,25]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llad312","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2023,9,11]]}}}